Circulating atypical cells detected in blood of lung cancer patients
New study data presented at the European Congress of Cytology – held from 3-6 Oct in Warsaw, Poland – confirmed that X-ZELL is able to detect tumour-associated circulating atypical cells in the blood of lung cancer patients. Read More →
This Startup Is Changing Cancer Detection Around the World (featuring X-ZELL)
X-ZELL is developing an accurate, affordable, and globally scalable early cancer detection from 10mL blood samples, which is unprecedented. Read More →